Integrated Echocardiography and Chest Ultrasound Assessment of Lung Recruitment in Preterm Infants

Recruiting N/A Interventional Study
Ventilator Lung Echocardiography Chest Ultrasound High Frequency Ventilation Lung Recruitment
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Hour – 3 Days
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
72 (estimated)
Sponsor
Alexandria University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The primary aim of this work is to evaluate the role of high frequency oscillatory ventilation (HFOV) in recruitment of lung in preterm newborns 32 to 37 weeks gestational age with moderate to severe respiratory distress. The secondary aim is to evaluate the role of chest ultrasound in monitoring of lung recruitment in comparison to routine chest x ray in those babies. Also cardiac hemodynamics wi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Infants will be enrolled if they are 32 to 37 weeks of gestational age, have respiratory distress (RD) in the first 24 h of life, intubated and have invasive respiratory support using HFOV. Signs of RD are tachypnea (respiratory rate \> 60/min), grunting, nasal flaring, chest …
Contacts

Marwa M Farag, PhD

01288681788

d.marwa.farag@gmail.com

CONTACT

Mohamed Hany Saad, MBBCh

01282226826

mohamedhany_90@icloud.com

CONTACT